O Klementieva
Overview
Explore the profile of O Klementieva including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia M, Paulus A, Vazquez-Reyes S, Klementieva O, Gouras G, Bachiller S, et al.
Brain Behav Immun Health
. 2023 Jul;
32:100663.
PMID: 37503358
Alzheimer's disease (AD) is the most common neurodegenerative disease. Most cases of AD are considered idiopathic and likely due to a combination of genetic, environmental, and lifestyle-related risk factors. Despite...
2.
Bachiller S, Hidalgo I, Garcia M, Boza-Serrano A, Paulus A, Denis Q, et al.
J Neuroinflammation
. 2022 Jun;
19(1):151.
PMID: 35705972
Background: The risk of developing Alzheimer's disease (AD) is modulated by genetic and environmental factors. Early-life stress (ELS) exposure during critical periods of brain development can impact later brain function...
3.
Klementieva O, Willen K, Martinsson I, Israelsson B, Engdahl A, Cladera J, et al.
Nat Commun
. 2017 Mar;
8:14726.
PMID: 28287086
Reducing levels of the aggregation-prone Aβ peptide that accumulates in the brain with Alzheimer's disease (AD) has been a major target of experimental therapies. An alternative approach may be to...
4.
Klementieva O, Aso E, Filippini D, Benseny-Cases N, Carmona M, Juves S, et al.
Biomacromolecules
. 2013 Sep;
14(10):3570-80.
PMID: 24004423
Poly(propylene imine) (PPI) glycodendrimers are promising candidates as drug carriers and antiamyloidogenic and antiprionic agents. In this study the anti-β-amyloid capacity of PPI glycodendrimers of the fourth and fifth generations...